Navigation Links
Interleukin Genetics Reports Fourth Quarter and Year End 2008 Financial Results
Date:3/9/2009

tion. The award was given for the paper, "Interleukin-1 genotype-selective inhibition of inflammatory mediators by a botanical: a nutrigenetics proof of concept," which was published in Nutrition: The International Journal of Applied and Basic Nutritional Sciences.
  • Enhanced Company Leadership. Throughout 2008, Interleukin Genetics, Inc. enhanced its management team with the addition of a new chief financial officer, vice president of marketing, senior business development executive, and staffed other critical positions in research and development, public relations, human resources, laboratory management and computer and information technology.
  • The Company reported revenues of $10.0 million and a net loss of $6.7 million, or $(0.21) per basic and diluted common share, for the year ended December 31, 2008, compared to revenues in 2007 of $9.7 million and a net loss of $6.2 million, or $(0.22) per basic and diluted common share. The revenue increase is primarily attributable to growth in consumer product revenue in combination with increased royalty and contract research revenue offset by a slight decrease in genetic testing revenue.

    Research and development expenses were $3.6 million for the year ended December 31, 2008 compared to $2.9 million for the year ended December 31, 2007. The increase is attributable to expenses relating to the Company's sponsored research agreement with Yonsei University, as well as additional expenses relating to our patent portfolio.

    Selling, general and administrative expenses were $7.0 million for the year ended December 31, 2008 compared to $6.4 million for the prior year. The increase is primarily attributable to increased promotional and advertising expenses, as well as increased expenses due to additional headcount.

    Fourth Quarter Results

    Revenue for the three months ended D
    '/>"/>

    SOURCE Interleukin Genetics, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. Interleukin Genetics Announces Management and Board Appointments
    2. Interleukin Genetics President and Chief Scientific Officer to Present at Immunotoxicology V Conference
    3. Interleukin Genetics, Inc. Reports Third Quarter 2007 Financial Results
    4. Interleukin Genetics Announces Conversion of $2.04 Million of Debt Into Common Stock
    5. Interleukin Genetics Enters into New Clinical Research Collaboration with Alticor
    6. Interleukin Genetics Retains Top Life Science Communications Firms
    7. Interleukin Genetics Announces Conference Call and Webcast to Discuss Fourth Quarter and Year End 2007 Business Results
    8. Interleukin Genetics Appoints Eliot M. Lurier Chief Financial Officer
    9. Interleukin Genetics Announces Conference Call and Webcast to Discuss First Quarter 2008 Business Results
    10. Interleukin Genetics to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference
    11. Interleukin Genetics Welcomes the Signing of the Genetic Information Nondiscrimination Act (GINA)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/18/2014)... (PRWEB) August 19, 2014 2014 ... Industry” is a professional and in-depth research report ... basic Linalool information, including its definition, classification, ... industry overview. This research covers the international market ... global industry analysis covering macroeconomic environment & economic ...
    (Date:8/18/2014)... --  Sterne, Kessler, Goldstein & Fox P.L.L.C. , an ... , announced today that it has filed eleven ... the U.S. Patent and Trademark Office (USPTO) on behalf ... (Nasdaq: BRLI).  These IPR petitions aim to nullify eleven ... These patents have been asserted against GeneDx in patent ...
    (Date:8/18/2014)... August 18, 2014 According ... Market, By Application (Municipal Wastewater Treatment and Industrial ... and Multi Tubular), By Configuration (Internal/Submerged and External/Sidestream), ... by MarketsandMarkets, The market for membrane bioreactor systems ... growing at a CAGR of 15.28% between 2014 ...
    (Date:8/18/2014)... , 18. August 2014 Vier ... eine internationale klinische Studie auf, in der ... Linse soll das Sehvermögen bei allen Entfernungen ... Operation möglicherweise keine Lese- oder Gleitsichtbrille mehr ... Namen FluidVision Accommodating Intraocular Lens ...
    Breaking Biology Technology:Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 2Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 4Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 2Sterne Kessler Files 11 IPR Petitions On Behalf Of GeneDx, Inc., Subsidiary Of BioReference Laboratories, Inc. 3Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 2Membrane Bioreactor Systems Market Worth $2,927 Million by 2019 3Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 2Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 3Implantation einer revolutionären akkommodativen Linse bei Katarakt-Patienten in deutschen Augenzentren im Rahmen einer internationalen klinischen Studie 4
    ... PharmAthene, Inc.,(Amex: PIP ), a biodefense ... threats, announced today that the Company,will present ... on its,Protexia(R) and Valortim(R) medical countermeasures programs ... Countermeasures Enterprise,(PHEMCE) Stakeholders Workshop 2008 / BARDA ...
    ... Equity, LLC issues a Q4/08,review of Neurobiological ... Outcome Scenarios, Probabilities Appear Focused to the ... at our website:, http://www.scimitarequity.com , Neurobiological ... in the business of acquiring and developing ...
    ... New Sales Agent and Distributor Gains Quick Traction in ... (BIEL) announced today that the new sales agent it ... for,approximately $400,000 in new sales in the Middle Eastern ... has hit the ground running and is,finding wide marketing ...
    Cached Biology Technology:PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008 2Neurobiological Technologies, Inc. (Nasdaq: NTII) Q4/08 Review Issued by Scimitar Equity, LLC 2BioElectronics Corp. Announces $400,000 in New Orders From the Middle East 2
    (Date:8/18/2014)... 2014 ,Trustonic TEE ... smart devices  Trustonic, the leading provider ... and Fingerprint Cards AB (FPC) today announced a ... secure biometric authentication on connected devices. ... (FPC1020, FPC1021 and FPC1150) and sensor driver software ...
    (Date:8/18/2014)... to a major Arizona watershed may lose access to ... water flow is reduced by the effects of climate ... species, found in the Verde River Basin, are already ... to various resources throughout the river and its tributary ... roundtail chub (Gila robusta) and Sonora sucker (Catostomus insignis). ...
    (Date:8/18/2014)... the University of Wisconsin-Madison, USA, have developed a new approach ... and land use change. This new metric was used to ... rates of climate and land use for the US from ... been published in Nature Climate Change , highlight areas ... ecosystem function due to the individual or combined effects of ...
    Breaking Biology News(10 mins):Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 2Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 3Trustonic and Fingerprint Cards Collaborate to Bring Secure Biometrics to Connected Devices 4Climate change will threaten fish by drying out Southwest US streams, study predicts 2Climate change will threaten fish by drying out Southwest US streams, study predicts 3The double threat of climate and land use change enhances risks to biodiversity 2
    ... light on the causes of Parkinson,s disease, researchers report that ... mitochondria. A shutdown in fuel can have devastating effects on ... energy despite making up only 2 percent of body weight. ... FDA approved drugs early on may prevent or delay the ...
    ... CAMBRIDGE, Mass. -- By creating a better way to ... with MIT,s Picower Institute for Learning and Memory and the ... synapse formation. These studies could also help further understanding of ... and Fragile X syndrome. The study will appear in the ...
    ... their dosages may be standardized, but not every patient ... personal genetic characteristics of individuals and populations can explain ... not another, so medical researchers are adopting the new ... lab is leading the way. Dr. Noam ...
    Cached Biology News:In Parkinson's disease, brain cells abandon mitochondria, researchers report 2In Parkinson's disease, brain cells abandon mitochondria, researchers report 3MIT researchers develop a better way to see molecules at work in living brain cells 2An X-ray for your genes 2
    ... The Genome Sequencer 20 System revolutionizes DNA ... parallel fashion. The Genome Sequencer 20 ... Reagents and consumables for library construction, ... mapping and de novo assembly ...
    ... is critical to the maintenance of ... proteins as important and diverse as ... shock and stress response, antigen presentation, ... ion channels, cell cycle regulation, transcription, ...
    Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential CV/Renal liabilities of compounds....
    ... demonstrated that oxidative stress is involved in ... stress is the condition in which an ... exist leading to the damage of a ... stress is through several antioxidant systems4 that ...
    Biology Products: